Suspension of trading
Centessa Pharmaceuticals plc Stock
Stocks
CNTA
US1523091007
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
00:00:00 24/06/2026 +04
|
5-day change | 1st Jan Change | ||
| 40.50 USD | +0.80% |
|
-.--% | +61.94% |
| 06-24 | Swiss Market Index Extends Rally; OC Oerlikon Shares Gain | MT |
| 06-24 | Eli Lilly Completes Acquisition of Centessa Pharmaceuticals | MT |
| Market Cap | 6.27B 5.37B 5.02B 4.6B 8.63B 600B 8.74B 59.34B 23.14B 301B 23.53B 23.02B 996B | P/E 2024 |
-8.13x | P/E 2025 | -17.2x |
|---|---|---|---|---|---|
| Enterprise Value | 6.09B 5.22B 4.88B 4.47B 8.39B 583B 8.5B 57.67B 22.49B 293B 22.87B 22.37B 968B | EV / Sales 2024 |
-
| EV / Sales 2025 | 231,810,355x |
| Free-Float |
78.43% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +0.80% | ||
| 3 months | +1.89% | ||
| 6 months | +65.31% | ||
| Current year | +61.94% |
| Current year | 21.5 |  | 40.56 |
| 1 year | 15.01 | | 40.56 |
| 3 years | 5.15 | | 40.56 |
| 5 years | 2.88 | | 40.56 |
| 10 years | 2.88 | | 40.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charlene Stoudt
CTO | Chief Tech/Sci/R&D Officer | - | 01/10/2024 |
Tia Bush
CTO | Chief Tech/Sci/R&D Officer | 55 | 01/03/2023 |
David Chao
ADM | Chief Administrative Officer | 58 | 01/04/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 24/06/2026 | |
Kristina Wright
BRD | Director/Board Member | - | 24/06/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24/06/26 | Medicxi Ventures (Jersey) Ltd.
| Sell | Company | -19,963,157 | 12.9020% | |
| 01/05/26 | Tax | Chief Executive Officer | -604 | 0.0004% | ||
| 02/02/26 | Free | Chief Financial Officer | 226,000 | 0.1691% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | -.--% | +134.38% | +533.80% | 6.27B | |
| +1.09% | +3.39% | +3.50% | +25.49% | 51.22B | |
| -1.07% | +2.82% | +474.18% | +601.24% | 45.38B | |
| +1.44% | +7.77% | +19.27% | +90.94% | 41.97B | |
| +1.47% | +7.58% | +35.29% | +21.42% | 42.15B | |
| -0.93% | -4.80% | +17.39% | +46.60% | 31.95B | |
| -0.60% | +1.93% | - | - | 16.73B | |
| +1.32% | +7.30% | +36.93% | +152.36% | 17.1B | |
| +0.03% | +3.91% | +5.84% | +35.04% | 14.76B | |
| +1.28% | +4.95% | +84.98% | +48.41% | 13.91B | |
| Average | +0.47% | +3.06% | +90.19% | +172.81% | 28.14B | |
| Weighted average by Cap. | +0.47% | +3.10% | +103.10% | +158.44% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | 15 12.85 12.02 11.01 20.65 1.44K 20.93 142.04 55.39 720.96 56.32 55.1 2.38K |
| Net income | -236M -202M -189M -173M -325M -22.56B -329M -2.23B -871M -11.33B -885M -866M -37.48B | -198M -169M -158M -145M -272M -18.9B -276M -1.87B -729M -9.49B -742M -726M -31.4B |
| Net Debt | -364M -312M -292M -267M -502M -34.86B -508M -3.45B -1.35B -17.51B -1.37B -1.34B -57.92B | -176M -151M -141M -129M -243M -16.86B -246M -1.67B -651M -8.47B -662M -647M -28.01B |
Employees
129
- Stock Market
- Stocks
- CNTA Stock
Select your edition
All financial news and data tailored to specific country editions
